Fine particles \[particles ≤ 2.5 μm diameter (PM~2.5~)\] originate from both local and regional pollution sources. A large fraction of PM~2.5~ mass is associated with the combustion of fuels such as gasoline, diesel, coal, oil, and wood. PM~2.5~ mass also includes crustal material (road dust and soil particles), sea salt, and biological particles. Factor analysis and source apportionment techniques \[[@b3-ehp-117-1168]; [@b44-ehp-117-1168]; [@b49-ehp-117-1168]\] have been used for many years to help policy regulators identify sources of particle pollution. These techniques have been used to investigate associations between sources of particle pollution and health effects including studies of adult mortality ([@b21-ehp-117-1168]; [@b24-ehp-117-1168]; [@b29-ehp-117-1168]; [@b39-ehp-117-1168]), adult emergency department visits ([@b36-ehp-117-1168]), and adult and pediatric hospital admissions ([@b1-ehp-117-1168]). Recently, one study associated specific sources of fine particles with respiratory morbidity in adults with asthma ([@b30-ehp-117-1168]).

PM~2.5~ mass concentration has been associated with adverse health effects in children, particularly children with asthma: increased respiratory morbidity and/or medication use ([@b11-ehp-117-1168]; [@b18-ehp-117-1168]; [@b23-ehp-117-1168]; [@b32-ehp-117-1168]; [@b33-ehp-117-1168]; [@b34-ehp-117-1168]; [@b38-ehp-117-1168]); increased number of doctor visits for respiratory illness ([@b5-ehp-117-1168]; [@b13-ehp-117-1168]; [@b31-ehp-117-1168]); and decreased lung function ([@b8-ehp-117-1168]; [@b15-ehp-117-1168]; [@b22-ehp-117-1168]; [@b26-ehp-117-1168]; [@b41-ehp-117-1168]). Linking respiratory health effects to specific particle pollution sources is critical to efforts to develop cost-effective strategies to protect public health, particularly the respiratory health of vulnerable members of the population such as children with asthma.

Annual PM~2.5~ levels at a monitoring site in New Haven, Connecticut, where subjects in the present study live, exceed the U.S. EPA annual standard of 15 μg/m^3^ ([@b45-ehp-117-1168]). We examined associations between daily exposure to PM~2.5~ components and sources identified through factor analysis and source apportionment, and daily symptoms and medication use in children with asthma. Some of the results of this study have been previously reported in the form of an abstract ([@b10-ehp-117-1168]).

Methods
=======

Subjects
--------

Subjects were drawn from a larger study population 4--12 years of age when enrolled between 2000 and 2003. Eligibility criteria were physician-diagnosed asthma and symptoms or medication use in the previous 12 months. Subjects in the present analysis (*n =* 149) were restricted to those residing in New Haven County within 30 km of the air quality monitor. Study participants included siblings with asthma (one per family; *n =*88, 59%) of infants enrolled in a birth cohort to study the development of asthma ([@b2-ehp-117-1168]), patients recruited from the Yale Pediatric Asthma Clinic (*n =*43, 29%), and children with asthma identified through a survey on childhood asthma conducted in the New Haven public schools (*n =* 18, 12%). In addition to abundant mobile sources of air pollution (e.g., interstate highways 95, 91, 84), New Haven is home to stationary sources including small manufacturing enterprises, power plants, and a harbor handling ships that deliver heating oil for New England ([@b44-ehp-117-1168]). New Haven County, population 824,008, covers an area of 2,233 km^2^ (863 mi^2^) ([@b42-ehp-117-1168]). Yale University Human Investigation Committee approved the study, and all respondents (mothers of study subjects) gave informed consent prior to participation.

Data collection
---------------

During the enrollment visit, a research assistant administered a questionnaire to the child's mother to collect demographic, medical history, and home environment information. Mothers recorded daily symptoms \[wheeze, persistent cough (defined as coughing throughout the day), shortness of breath, chest tightness, night symptoms\] and medication use (rescue medication including bronchodilators, and maintenance medication including steroids, cromolyn sodium, and leukotriene inhibitors) on study diaries and reported this information during monthly telephone interviews. Dates away from New Haven during the follow-up period were reported at an exit interview and were not used in the analysis.

Exposure measurements
---------------------

### Filter analysis

PM~2.5~ filter samples (*n* = 1,181) were collected between 1 August 2000 and 3 February 2004 from the Stiles Street monitoring site (98% of the filters) or the State Street site (within 3 km). Filters were analyzed by X-ray fluorescence (XRF) (Desert Research Institute, Reno, Nevada) ([@b48-ehp-117-1168]). A list of the 51 elements analyzed is presented in the Supplemental Material, [Table 1](#t1-ehp-117-1168){ref-type="table"} (available online at <http://www.ehponline.org/members/2009/0800335/suppl.pdf>).

### Light reflectance analysis

Before XRF, elemental carbon (EC) concentrations were determined using an optical reflectance technique ([@b7-ehp-117-1168]; [@b17-ehp-117-1168]; [@b20-ehp-117-1168]). See Supplemental Material for further details (available online at <http://www.ehponline.org/members/2009/0800335/suppl.pdf>).

### Source apportionment

We analyzed daily concentrations of 17 elements \[see Supplemental Material, [Table 1](#t1-ehp-117-1168){ref-type="table"} (available online at <http://www.ehponline.org/members/2009/0800335/suppl.pdf>)\] as well as EC using principal component analysis with an orthogonal (varimax) rotation in SAS (version 9.1; SAS Institute Inc., Cary, NC) ([@b19-ehp-117-1168]; [@b40-ehp-117-1168]). We calculated daily scores for each factor by multiplying the normalized elemental concentrations by the respective standardized elemental scoring coefficient and factor, then summing across all component products. Scores were rescaled to concentrations in micrograms per cubic meter by regressing total PM~2.5~ concentration on factor scores and obtaining the product of each factor score with its regression coefficient. Rescaled factor scores, or daily source contributions, were used as exposures in the health effects analyses.

Six sources of PM~2.5~ were identified based on loadings (or correlations) of elements on each of the six factors determined by factor analysis. The factor with high loadings for EC and trace elements zinc, lead, and copper was attributed to motor vehicle emissions. The factor road dust was associated with elements of terrestrial origin such as silicon, iron, aluminum, and calcium as well as barium, which is a tracer for tire wear particles. The sulfur factor represents particles from regional sources and was highly correlated with the elements sulfur and phosphorus. The factor with a high potassium loading was attributed to biomass burning. The oil factor represents oil combustion emissions from power plants and home heating and was characterized by the presence of vanadium and nickel. Finally, the sea salt factor was associated with the elements sodium and chlorine.

Data analysis
-------------

The association between daily elemental concentrations or source contributions and daily respiratory symptoms and rescue medication use was examined with repeated measures logistic regression (SAS Institute Inc.). Models used generalized estimating equations (GEE) specifying a 1-day lag autoregressive structure (AR1) for the health outcomes correlation matrices. All models were adjusted for season using sine and cosine functions of date to capture annual cycles \[i.e., cos((date/365) × 2π) and sin((date/365) × 2π)\], day of week (for weekly cycles), and date (to control for time trends over the 4-year course of the study). Because sources were uncorrelated by design (orthogonal rotation of factors), all six sources were included simultaneously in health effects models. Gaseous co-pollutants (nitrogen dioxide, carbon monoxide, sulfur dioxide, ozone) were examined separately in models that also included all six sources. Models included year-round data except for the co-pollutant model with O~3~, which is monitored only in warm months. Health effects of elements included in the factor analysis, all six sources, and PM~2.5~ were examined for same-day exposures \[lag0 (L0)\] as well as exposures lagged by 1 or 2 days (L1, L2) or the mean of lagged days 0--2 (L02). Tests for goodness of fit were performed using the Hosmer--Lemeshow statistic for logistic regression.

Results
=======

Demographic characteristics of study participants are shown in [Table 1](#t1-ehp-117-1168){ref-type="table"}. Most subjects were male (60%), ≥ 8 years of age (53%) (mean ± SD = 8 ± 2 years), and self-reported as white (56%). More than one-third of the adult respondents had a college degree (36%). Environmental tobacco smoke exposure was reported in 6% of the homes. Subjects participated for a mean of 313 ± 92 days \[median 366; interquartile range (IQR) 54 days\]. The distribution of daily symptoms and medication use is shown in [Table 2](#t2-ehp-117-1168){ref-type="table"}. The most frequently experienced symptom was persistent cough (reported by 86%), followed by wheeze (76%), which was experienced by subjects for a median of 19 days (IQR 29) or 8 days (IQR 24), respectively, of the year of follow-up. Subjects experienced shortness of breath or chest tightness (reported by two-thirds of the subjects) less frequently for a median of 4 (IQR 14) days each, and used short-acting inhalers (reported by 80%) for a median of 18 (IQR 47) days. Nearly one-third of the subjects had moderate to severe persistent asthma during the year-long follow-up study ([Table 2](#t2-ehp-117-1168){ref-type="table"}). All subjects resided 0.9--27 km from the air pollution monitor site (mean ± SD = 10.2 ± 8.4 km). The mean number of subjects under observation each day was 36 ± 8 and ranged from 10 to 49. The mean number of subjects experiencing symptoms or using short-acting inhalers each day was as follows: shortness of breath or chest tightness 3 ± 3%; wheeze 5 ± 4%; persistent cough 8 ± 5%; and inhaler use 12 ± 6% ([Figure 1A,B](#f1-ehp-117-1168){ref-type="fig"}).

Mean level of PM~2.5~ during the study was 17.0 ± 9.8 μg/m^3^, which is above the U.S. annual standard for fine particles of 15 μg/m^3^ ([@b45-ehp-117-1168]). The contributions from each source to PM~2.5~ mass and to elemental components of PM~2.5~ are given in [Table 3](#t3-ehp-117-1168){ref-type="table"}. The mean estimated and measured mass are given as well as the percent root mean square error (%RMSE), defined as 100 × (\|estimated concentration -- measured concentration\|/measured concentration). Elemental components of PM~2.5~ are grouped according to the source with which they were most strongly associated. For example, the motor vehicle source contributed 62% of the estimated mean EC mass (961.3 of 1554.8 ng/m^3^) and 77% of the mean Zn mass (22.3 of 29.0 ng/m^3^). On average, over the 4 years of the study, over half of daily PM~2.5~ came from the two traffic-related sources motor vehicles \[median (IQR) 42.5% (26.7%)\] and road dust \[12.3% (13.8%)\] (bottom of [Table 2](#t2-ehp-117-1168){ref-type="table"}). An additional 28.7% (30.3%) of daily PM~2.5~ came from regional sulfur sources.

The associations between PM~2.5~ elemental components and daily symptoms or medication use are presented in [Table 4](#t4-ehp-117-1168){ref-type="table"}. Individual elements in fine particle mass may come from more than one source but are listed in [Table 4](#t4-ehp-117-1168){ref-type="table"} according to the source with which they were most strongly associated ([Table 3](#t3-ehp-117-1168){ref-type="table"}). Associations for same-day exposure (L0) and exposures averaged over the same day and previous 2 days (L02) are shown in [Table 4](#t4-ehp-117-1168){ref-type="table"}. Exposures lagged by 1 or 2 days (L1, L2) are included in [Table 2](#t2-ehp-117-1168){ref-type="table"} in the Supplemental Material (available online at <http://www.ehponline.org/members/2009/0800335/suppl.pdf>). In general, trace elements originating from the motor vehicle, road dust, biomass burning, and oil sources are associated with symptoms and/or medication use. For example, a significantly increased likelihood of wheeze, shortness of breath, chest tightness, or short-acting inhaler use is associated with each 1,000-ng/m^3^ increase in EC. The strongest associations were found for the 3-day averaged exposures to the elemental constituents of road dust. No associations were found between individual elements associated with sulfur or sea salt sources and symptoms or medication use. Total PM~2.5~ was not significantly associated with any symptoms or medication use \[see Supplemental Material, [Table 3](#t3-ehp-117-1168){ref-type="table"} (available online at <http://www.ehponline.org/members/2009/0800335/suppl.pdf>)\].

Daily source contributions to PM~2.5~ are illustrated for the 4 years of the study in [Figure 1C--1H](#f1-ehp-117-1168){ref-type="fig"}. Results of logistic regression models examining associations between health outcomes and PM~2.5~ sources are shown in [Table 5](#t5-ehp-117-1168){ref-type="table"} for same-day exposures ([Table 5](#t5-ehp-117-1168){ref-type="table"}, L0 model) and exposures averaged over the same day and previous 2 days ([Table 5](#t5-ehp-117-1168){ref-type="table"}, L02 model). Source exposures lagged by 1 or 2 days (L1, L2) are included in the Supplemental Material, [Table 3](#t3-ehp-117-1168){ref-type="table"} (available online at <http://www.ehponline.org/members/2009/0800335/suppl.pdf>). For same-day or 3-day averaged exposures, each 5-μg/m^3^ increase in PM~2.5~ mass concentration coming from either motor vehicles or road dust is consistently associated with increases in the likelihood of respiratory symptoms or inhaler use ([Table 5](#t5-ehp-117-1168){ref-type="table"}). Reduced likelihood of wheeze or inhaler use is associated with 5-μg/m^3^ increases in the same day, but not for lagged exposures to the sulfur source. Significant reductions in the likelihood of wheeze were also associated with exposures to the biomass burning source.

The effect of adding a gaseous co-pollutant (NO~2~, CO, SO~2~, or O~3~) to the source exposure model is shown for wheeze and short-acting inhaler use in [Table 6](#t6-ehp-117-1168){ref-type="table"}. For example, the addition of any of the gaseous co-pollutants to the source exposure model reduces the effect of the motor vehicle source on wheeze. Interestingly, in the source model that also includes NO~2~ (another marker for traffic), each 20-ppb increase in NO~2~ increases the likelihood of wheeze by 8% (*p* = 0.09). No significant associations were seen in co-pollutant models between exposure and likelihood of persistent cough or chest tightness.

Discussion
==========

Results of the source apportionment analysis suggest that over half of the mean PM~2.5~ can be attributed to traffic sources motor vehicles and road dust, and that daily exposure to these sources is associated with increased risk of respiratory symptoms and inhaler use in children with asthma. Risks remain in models that include all six PM~2.5~ sources as well as one gaseous co-pollutant. Of co-pollutants added to the model one at a time, NO~2~, which is a marker for traffic ([@b12-ehp-117-1168]), was also found to be an independent risk factor for increased wheeze ([Table 6](#t6-ehp-117-1168){ref-type="table"}).

In single-element analyses, EC, also considered a marker for traffic ([@b12-ehp-117-1168]; [@b36-ehp-117-1168]), is itself associated with increased symptoms (wheeze, shortness of breath, chest tightness) and medication use ([Table 4](#t4-ehp-117-1168){ref-type="table"}). Of the EC measured in PM~2.5~, 88% was contributed by the traffic-related sources: 62% from motor vehicles and 26% from road dust ([Table 3](#t3-ehp-117-1168){ref-type="table"}). Among elements associated with the road dust source, Ca appears to have the strongest association with symptoms ([Table 4](#t4-ehp-117-1168){ref-type="table"}). Numerous studies have found that the composition of Ca in road dust is higher than that in the earth's crust ([@b12-ehp-117-1168]). Results from tunnel and chassis dynamometer studies have shown that Ca is emitted from light and heavy-duty vehicles and is possibly associated with the combustion of motor oil ([@b28-ehp-117-1168]). The stronger associations with fine-particle Ca compared with other major terrestrial elements such as Al and Si suggests that it may be a better tracer of urban road dust.

A negative association was observed between biomass burning and wheeze ([Table 5](#t5-ehp-117-1168){ref-type="table"}). Potassium, the tracer element for biomass burning source and an element used in firework propellant mixture, was present at high concentrations when Fourth of July displays took place ([@b25-ehp-117-1168]). When the analysis was rerun without the days with the five highest potassium values \[all \> 1,000 ng/m^3^ and all occurring in July (4 July 20014 July 20024 July 2003; 5 July 2003; 7 July 2002) ([Figure 1F](#f1-ehp-117-1168){ref-type="fig"})\], the negative association seen previously for wheeze remains but is no longer significant \[odds ratio (OR) 0.85; *p* = 0.29\]. Of note is the high level of potassium measured on 7 July 2002, which is attributable not to fireworks but to a smoke plume from a massive Canadian forest fire ([@b37-ehp-117-1168]). For our subjects, symptoms and medication use are at their lowest in summer and highest in winter ([Figure 1A,B](#f1-ehp-117-1168){ref-type="fig"}), and if these children with asthma were kept away from fireworks displays and/or kept indoors during the smoke plume days, this may have resulted in the apparent protective association with potassium levels.

Subjects who were in follow-up during the summer of 2001 also contributed data to an earlier analysis of O~3~ and respiratory health in southern New England ([@b11-ehp-117-1168]). In that analysis, we found O~3~ exposure to be a risk for increased respiratory symptoms, but only among children taking asthma maintenance medication (e.g., corticosteroids). The model with PM~2.5~ sources and O~3~ shown in [Table 6](#t6-ehp-117-1168){ref-type="table"} shows O~3~ to be a risk factor increasing the likelihood of wheeze by 8% (*p* = 0.08), but this model includes data from all children living in New Haven regardless of maintenance medication status. Reanalysis stratified by maintenance medication use showed that every 50-ppb increase in O~3~ (8-hr average) resulted in a larger risk of wheeze for users of maintenance medication (*n =*76) \[OR = 1.29; 95% confidence interval (CI), 0.99--1.68; *p* = 0.06\] than for nonusers (*n =*63) (OR = 1.10; 95% CI, 0.77--1.57; *p* = 0.60). Comparable results from the earlier report are given for a 50-ppb increase in 1-hr O~3~: For children on maintenance medication (*n =* 130), the likelihood of wheeze increases by 35% (OR = 1.35; 95% CI, 1.11--1.65) ([@b11-ehp-117-1168]).

Although exposure to total PM~2.5~ mass has itself been shown to be a significant risk factor for adverse respiratory outcomes among children ([@b18-ehp-117-1168]; [@b23-ehp-117-1168]; [@b32-ehp-117-1168]; [@b33-ehp-117-1168]; [@b34-ehp-117-1168]; [@b38-ehp-117-1168]), this is not always the case ([@b6-ehp-117-1168]; [@b14-ehp-117-1168]). In a study of Medicaid claims for doctor visits for asthma in Anchorage, Alaska, the authors noted that the major constituent of their particles is geologic in origin (i.e., rock dust), and that annual levels of PM mass are low, 6 μg/m^3^ (95% CI, 0.5--7.0). The authors found no association between exposure to PM~2.5~ mass and health outcomes. On the other hand, significant effects were seen between increases in PM~10~ mass concentrations (PM with aerodynamic diameter \< 10 μm) and increased visits for asthma and prescriptions for inhalers ([@b6-ehp-117-1168]). In a study of asthmatic children and respiratory health in a busy, traffic-filled Mexican border town, [@b14-ehp-117-1168] found no significant association between level of PM~2.5~ mass and respiratory health. However, using traffic as the exposure metric (calculated as traffic density in 50-m residential buffers) revealed a significant risk for increased respiratory symptoms with increasing traffic (OR = 1.58; 95% CI, 1.05--2.38) ([@b14-ehp-117-1168]).

Studies using proximity to traffic as an exposure metric suggest that children living near busy roads have impaired respiratory health. Large studies of schoolchildren in Munich ([@b27-ehp-117-1168]) and Nottingham, United Kingdom ([@b47-ehp-117-1168]), have found that proximity of residence (\< 50--90 m) to heavily traveled roads is associated with increased risk of asthma symptoms. Studies of schoolchildren conducted in the Netherlands found increased health risks associated with proximity specifically to truck traffic and wheeze ([@b16-ehp-117-1168]), chronic respiratory symptoms ([@b46-ehp-117-1168]), and lung function ([@b4-ehp-117-1168]). Similar increased risk associations were found between black smoke (a proxy for diesel exhaust), measured at subjects' schools, and respiratory outcomes. No significant associations were found between respiratory symptoms and volume of automobile traffic. The strongest associations were found for children living within 300 m of a highway ([@b4-ehp-117-1168]). A smaller study in Cincinnati, Ohio ([@b35-ehp-117-1168]), found an increased risk of wheezing in infants associated with stop-and-go bus and truck traffic within 100 m of the residence. All of these studies suggest that proximity to traffic, in particular high-volume truck traffic, has a negative impact on the respiratory health of children. Rather than a metric based on proximity to roads or traffic density, we used factor analysis and source apportionment techniques to examine exposures to potentially toxic portions of particle mass and the health of children residing in an area of significant mobile source activity.

One strength of this study is its longitudinal design. More than 46,000 subject-days of data were available for analyses (resulting in small CIs) where each subject served as his or her own control for potential confounders. Effect estimates from analyses where sex, age, ethnicity, parental education level, and exposure to environmental tobacco smoke were also included varied little from those shown in [Table 6](#t6-ehp-117-1168){ref-type="table"}. For example, each 5-μg/m^3^ increase in exposure to motor vehicle source was associated with identical increased risks of wheeze and shortness of breath and inhaler use. Likewise, the risk estimates associated with exposure to road dust source were identical for persistent cough and inhaler use and slightly decreased for wheeze (OR = 1.09; 95% CI, 1.01--1.19) and shortness of breath (OR = 1.11; 95% CI, 1.02--1.21) (for comparison, see [Table 5](#t5-ehp-117-1168){ref-type="table"}). Goodness-of-fit tests suggest that the models for wheeze and chest tightness are reasonably good fits to the data ([Table 5](#t5-ehp-117-1168){ref-type="table"}). There were no systematic patterns to the lack of fit for models for persistent cough, shortness of breath, or short-acting inhaler use. However, because of the repeated measurements, observations were not independent in any of the models, which may affect the interpretation of the Hosmer--Lemeshow statistic. It is possible that the more frequently reported events of persistent cough and short-acting inhaler use ([Table 2](#t2-ehp-117-1168){ref-type="table"}) may be associated with ambient air pollution in combination with other factors (e.g., activity level) not included in the current study.

One limitation of our study is the lack of co-located EC calibration measurements. Previous studies have used thermal optical reflectance (TOR) to measure EC collected on quartz filters in co-located monitors. TOR, a relatively costly but accurate measure of EC, is used to calibrate EC estimated by the much less expensive light reflectance measures on Teflon filters. We assumed a factor of 1 based on calibration factors reported in other studies examining air pollution in urban settings ([@b7-ehp-117-1168]; [@b20-ehp-117-1168]) and on our own results of TOR EC measurements on 30, co-located quartz filters \[see Supplemental Material (available online at <http://www.ehponline.org/members/2009/0800335/suppl.pdf>)\].

Another limitation to our study is our reliance on a central site monitor. It is likely that measurements from this site, located on an on-ramp to I-95 at the southern edge of New Haven County, represent the highest end of the exposure distribution. Exposure error for regional sources, for example, sulfur, is probably low because of its homogeneity within the study area. On the other hand, local traffic exposures vary across the study area, which may have led to an overestimate of subjects' exposures to motor vehicle and road dust sources and an underestimate of health effects; that is, it is possible that levels lower than those used have significant adverse effects on respiratory health of children with asthma in our region. Determination of spatial variability of PM~2.5~ away from central site monitors will be needed to improve assessment of exposures actually experienced by vulnerable populations.

Conclusions
===========

The composition of ambient fine particles is complex, because it depends on emission sources and atmospheric processes. The U.S. EPA national air quality standard for PM~2.5~ considers only mass and not composition ([@b45-ehp-117-1168]). However, health impacts associated with exposures to specific particle components or sources, especially for vulnerable populations, may be missed with this aggregate characterization ([@b9-ehp-117-1168]; [@b36-ehp-117-1168]). Apportioning fine particle mass according to contributing sources may help unmask source-specific associations. For children with asthma living in an area of noncompliance with PM~2.5~ standards, increased risk of daily symptoms and medication use was associated with daily traffic-related fine particle sources.

Supplemental Material is available online at <http://www.ehponline.org/members/2009/0800335/suppl.pdf>
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###### 

Personal characteristics for children participating in a year-long prospective study (*n =* 149), New Haven, Connecticut, August 2000--January 2004.

  Enrollment characteristic                                                No. (%)
  ------------------------------------------------------------------------ ------------
  Sex                                                                      
   Male                                                                    89 (59.7)
   Female                                                                  60 (40.3)
  Ethnicity                                                                
   White                                                                   84 (56.4)
   Black                                                                   36 (24.2)
   Hispanic                                                                27 (18.1)
   Other                                                                   2 (1.3)
  Age at enrollment (years)                                                
   \< 8                                                                    70 (47.0)
   ≥ 8                                                                     79 (53.0)
  Mother's education (years)[a](#tfn1-ehp-117-1168){ref-type="table-fn"}   
   \< 12                                                                   13 (8.7)
   12--15                                                                  83 (55.7)
   \> 15                                                                   53 (36.0)
  Environmental exposure to tobacco smoke                                  
   No                                                                      140 (94.0)
   Yes                                                                     9 (6.0)

The adult respondent was the subject's mother in all but two homes.

###### 

Distribution of daily symptoms, daily inhaler use, and mean asthma severity during a year-long prospective study (*n =* 149), New Haven, Connecticut, August 2000--January 2004.

  Variable                                                                    No. (%)
  --------------------------------------------------------------------------- -----------
  Symptoms and inhaler use during 12-month study period (days)                
   Wheeze                                                                     
    None                                                                      35 (23.5)
    1--7                                                                      36 (24.2)
    8--14                                                                     22 (14.8)
    15--21                                                                    15 (10.1)
    22--29                                                                    11 (7.4)
    ≥ 30                                                                      30 (20.1)
   Persistent cough                                                           
    None                                                                      20 (13.5)
    1--7                                                                      31 (21.0)
    8--14                                                                     12 (8.1)
    15--21                                                                    17 (11.5)
    22--29                                                                    21 (14.2)
    ≥ 30                                                                      47 (31.8)
   Shortness of breath                                                        
    None                                                                      46 (30.9)
    1--7                                                                      43 (28.9)
    8--14                                                                     23 (15.4)
    15--21                                                                    9 (6.0)
    22--29                                                                    9 (6.0)
    ≥ 30                                                                      19 (12.8)
   Chest tightness                                                            
    None                                                                      49 (32.9)
    1--7                                                                      44 (29.5)
    8--14                                                                     20 (13.4)
    15--21                                                                    9 (6.0)
    22--29                                                                    7 (4.7)
    ≥ 30                                                                      20 (13.4)
   Short-acting inhaler use                                                   
    None                                                                      29 (19.5)
    1--7                                                                      28 (18.8)
    8--14                                                                     14 (9.4)
    15--21                                                                    11 (7.4)
    22--29                                                                    11 (7.4)
    ≥ 30                                                                      56 (37.6)
   Asthma severity (GINA score)[a](#tfn2-ehp-117-1168){ref-type="table-fn"}   
    0 No symptoms/medication                                                  5 (3.4)
    1 Intermittent                                                            66 (44.9)
    2 Mild persistent                                                         29 (19.7)
    3 Moderate persistent                                                     30 (20.4)
    4 Severe persistent                                                       17 (11.6)

A five-point asthma severity score \[from 0 (no symptoms or medication use) to 4 (severe persistent)\], based on the Global Initiative for Asthma guidelines ([@b43-ehp-117-1168]) was calculated for each month of the study. The mean severity was the arithmetic mean of the 12 monthly severity scores.

###### 

Source contributions[a](#tfn4-ehp-117-1168){ref-type="table-fn"} to PM~2.5~ mass (μg/m^3^) and elemental (ng/m^3^) concentrations in New Haven, Connecticut, August 2000 -- January 2004.

                                             Source                                              Mass                                                                                                                                                                                                                                                                              
  ------------------------------------------ --------------------------------------------------- --------------------------------------------------- --------------------------------------------------- -------------------------------------------------- ------------------------------------------------- -------------------------------------------------- -------- -------- ------
  Element (ng/m^3^)                                                                                                                                                                                                                                                                                                                                                                
   EC                                        961.3[b](#tfn5-ehp-117-1168){ref-type="table-fn"}   403.4                                               118.8                                               22.1                                               68.1                                              --19.0                                             1554.8   1894.5   17.9
   Zn                                        22.3[b](#tfn5-ehp-117-1168){ref-type="table-fn"}    2.6                                                 0.8                                                 0.5                                                1.7                                               1.0                                                29.0     23.0     26.3
   Pb                                        3.4[b](#tfn5-ehp-117-1168){ref-type="table-fn"}     0.5                                                 0.6                                                 0.5                                                ---                                               0.1                                                5.1      4.9      4.0
   Cu                                        2.1[b](#tfn5-ehp-117-1168){ref-type="table-fn"}     1.3                                                 0.5                                                 1.8                                                0.2                                               ---                                                6.0      6.3      5.5
   Se                                        0.4[b](#tfn5-ehp-117-1168){ref-type="table-fn"}     --0.1                                               0.2                                                 ---                                                0.0                                               0.0                                                0.5      0.5      3.5
   Si                                        --4.5                                               115.7[b](#tfn5-ehp-117-1168){ref-type="table-fn"}   5.7                                                 4.8                                                2.0                                               2.2                                                125.9    117.0    7.6
   Fe                                        84.7                                                101.1[b](#tfn5-ehp-117-1168){ref-type="table-fn"}   3.0                                                 11.6                                               12.2                                              --1.7                                              210.9    219.0    3.7
   Al                                        --7.0                                               54.8[b](#tfn5-ehp-117-1168){ref-type="table-fn"}    7.0                                                 5.8                                                ---                                               1.6                                                62.0     67.5     8.1
   Ca                                        17.8                                                29.1[b](#tfn5-ehp-117-1168){ref-type="table-fn"}    ---                                                 1.5                                                1.1                                               2.0                                                51.6     51.2     0.7
   Ba                                        2.9                                                 4.9[b](#tfn5-ehp-117-1168){ref-type="table-fn"}     0.5                                                 4.1                                                0.8                                               --0.4                                              12.7     12.6     0.4
   Ti                                        1.2                                                 4.2[b](#tfn5-ehp-117-1168){ref-type="table-fn"}     0.5                                                 0.9                                                ---                                               ---                                                6.9      7.4      6.3
   S                                         210.4                                               166.3                                               906.7[b](#tfn5-ehp-117-1168){ref-type="table-fn"}   75.4                                               18.7                                              26.0                                               1403.4   1451.8   3.3
   P                                         14.0                                                6.6                                                 36.8[b](#tfn5-ehp-117-1168){ref-type="table-fn"}    2.6                                                1.5                                               ---                                                61.5     64.8     5.2
   K                                         --8.0                                               13.8                                                12.4                                                60.5[b](#tfn5-ehp-117-1168){ref-type="table-fn"}   --2.7                                             3.7                                                79.6     63.2     25.8
   V                                         0.6                                                 1.1                                                 0.8                                                 0.2                                                6.0[b](#tfn5-ehp-117-1168){ref-type="table-fn"}   0.2                                                8.9      9.9      9.4
   Ni                                        1.9                                                 0.4                                                 0.2                                                 0.1                                                2.6[b](#tfn5-ehp-117-1168){ref-type="table-fn"}   0.2                                                5.6      5.2      6.9
   Na                                        20.9                                                29.3                                                37.0                                                4.4                                                ---                                               47.0[b](#tfn5-ehp-117-1168){ref-type="table-fn"}   140.1    180.8    22.5
   Cl                                        20.5                                                ---                                                 --11.2                                              ---                                                6.9                                               32.0[b](#tfn5-ehp-117-1168){ref-type="table-fn"}   48.7     29.6     64.4
  PM~2.5~ (μg/m^3^)                          6.6[b](#tfn5-ehp-117-1168){ref-type="table-fn"}     2.3                                                 5.5                                                 0.9                                                0.8                                               0.5                                                16.6     17.0     2.4
  Daily source contribution to PM~2.5~ (%)                                                                                                                                                                                                                                                                                                                                         
   Median                                    42.5                                                12.3                                                28.7                                                4.4                                                2.2                                               1.2                                                                  
   IQR                                       26.7                                                13.8                                                30.3                                                5.6                                                7.7                                               7.2                                                                  

nonsignificant contribution.

Mean concentration for 1,181 days between August 2000 and January 2004.

Maximum contribution from a particular source for each element.

###### 

ORs from separate repeated measures logistic regression analyses[a](#tfn7-ehp-117-1168){ref-type="table-fn"} of associations between daily respiratory symptoms and each daily elemental concentration of PM~2.5~.

                                  Wheeze   Persistent cough   Shortness of breath   Chest tightness   Inhaler short-acting                                
  ----------------- ----- ------- -------- ------------------ --------------------- ----------------- ---------------------- ------- ------ ------ ------ -------
  Motor vehicles                                                                                                                                          
                                                                                                                                                          
   EC               L0    1,000   1.04     0.04               1.01                  0.42              1.06                   0.001   1.03   0.20   1.01   0.15
                    L02   1,000   1.07     0.06               1.03                  0.23              1.12                   0.01    1.10   0.04   1.02   0.40
   Zn               L0    10      1.00     0.69               1.00                  0.60              1.02                   0.001   1.00   0.72   1.00   0.41
                    L02   10      1.00     0.98               1.00                  0.94              1.04                   0.06    1.03   0.13   1.01   0.53
   Pb               L0    5       1.02     0.31               1.02                  0.25              1.03                   0.11    1.02   0.31   1.01   0.06
                    L02   5       1.07     0.13               1.05                  0.12              1.12                   0.01    1.10   0.02   1.04   0.10
   Cu               L0    5       1.01     0.59               1.02                  0.13              1.06                   0.01    1.03   0.23   1.01   0.22
                    L02   5       1.02     0.67               1.05                  0.04              1.06                   0.21    1.04   0.39   1.01   0.46
   Se               L0    1       1.00     0.97               1.00                  0.84              1.02                   0.40    1.00   0.79   0.99   0.20
                    L02   1       1.02     0.71               0.98                  0.43              1.02                   0.67    0.98   0.61   0.99   0.75
                                                                                                                                                          
  Road dust                                                                                                                                               
                                                                                                                                                          
   Si               L0    100     1.03     0.03               1.02                  0.01              1.04                   0.01    1.02   0.20   1.02   0.004
                    L02   100     1.07     0.04               1.05                  0.02              1.08                   0.02    1.06   0.10   1.03   0.09
   Fe               L0    100     1.04     0.02               1.02                  0.06              1.06                   0.002   1.01   0.47   1.02   0.004
                    L02   100     1.07     0.05               1.04                  0.04              1.08                   0.04    1.05   0.21   1.03   0.08
   Al               L0    50      1.02     0.17               1.03                  0.002             1.05                   0.002   1.02   0.21   1.02   0.02
                    L02   50      1.07     0.03               1.06                  0.01              1.09                   0.004   1.07   0.04   1.02   0.11
   Ca               L0    50      1.07     0.02               1.05                  0.01              1.10                   0.002   1.04   0.26   1.04   0.01
                    L02   50      1.14     0.04               1.09                  0.03              1.18                   0.01    1.14   0.07   1.04   0.17
   Ba               L0    10      0.99     0.57               1.00                  0.83              1.04                   0.02    1.01   0.63   1.01   0.08
                    L02   10      0.99     0.81               1.00                  0.81              1.03                   0.38    1.02   0.51   1.01   0.36
   Ti               L0    5       1.00     0.59               1.00                  0.57              1.01                   0.01    1.00   0.34   1.00   0.72
                    L02   5       1.01     0.56               1.01                  0.29              1.03                   0.05    1.01   0.52   1.00   0.66
                                                                                                                                                          
  Sulfur                                                                                                                                                  
                                                                                                                                                          
   S                L0    1,000   0.98     0.43               1.00                  0.84              1.01                   0.63    0.99   0.80   0.99   0.13
                    L02   1,000   1.00     0.99               1.02                  0.27              1.01                   0.79    1.02   0.68   1.00   0.81
   P                L0    50      0.98     0.39               1.00                  0.75              1.01                   0.61    1.00   0.88   0.98   0.15
                    L02   50      0.99     0.89               1.03                  0.30              1.01                   0.78    1.02   0.67   1.00   0.99
                                                                                                                                                          
  Biomass burning                                                                                                                                         
                                                                                                                                                          
   K                L0    50      0.98     0.06               1.00                  0.64              1.01                   0.01    1.01   0.02   1.00   0.68
                    L02   50      0.96     0.04               1.00                  0.86              1.00                   0.79    0.99   0.67   0.99   0.28
                                                                                                                                                          
  Oil                                                                                                                                                     
                                                                                                                                                          
   V                L0    10      0.99     0.73               1.01                  0.56              1.01                   0.46    0.99   0.71   0.98   0.12
                    L02   10      0.93     0.04               0.96                  0.05              0.98                   0.58    0.94   0.12   0.96   0.03
   Ni               L0    5       1.01     0.59               1.01                  0.21              1.04                   0.05    1.01   0.58   1.01   0.48
                    L02   5       0.99     0.72               1.00                  0.99              1.04                   0.32    1.01   0.84   1.01   0.48
                                                                                                                                                          
  Sea salt                                                                                                                                                
                                                                                                                                                          
   Na               L0    100     0.98     0.23               1.00                  0.58              1.00                   0.94    0.99   0.43   0.99   0.35
                    L02   100     0.97     0.29               0.98                  0.21              0.99                   0.74    0.98   0.61   0.99   0.37
   Cl               L0    10      1.00     0.89               1.00                  0.31              1.00                   0.89    1.00   0.24   1.00   0.69
                    L02   10      1.00     0.81               1.00                  0.06              1.00                   0.80    1.00   0.65   1.00   0.83

Associations are shown for same-day exposure (L0) and averaged over the same day and previous 2 days (L02). n = 149 children with asthma, New Haven, Connecticut, August 2000--January 2004.

Separate analyses were performed for each element and each respiratory symptom and medication use. Models were adjusted for season, day of week, and date. ORs are given for the unit increase given in the second column for each element (and EC). Individual elements in fine particle mass may come from more than one source but are listed here according to their major source. See [Table 3](#t3-ehp-117-1168){ref-type="table"} for the contribution of each source to each element's total mass. Results from analyses using elemental exposures lagged by 1 or 2 days (L1, L2) are included in Supplemental Material, [Table 2](#t2-ehp-117-1168){ref-type="table"} (available online at <http://www.ehponline.org/members/2009/0800335/suppl.pdf>).

###### 

ORs (95% CIs) from repeated measures logistic regression models of respiratory symptoms and rescue medication use and daily source concentrations of PM~2.5~.

  Source             Wheeze              Persistent cough    Shortness of breath   Chest tightness     Inhaler short-acting
  ------------------ ------------------- ------------------- --------------------- ------------------- ----------------------
  L0 model                                                                                             
   Motor vehicles    1.05 (0.99--1.10)   1.02 (0.99--1.04)   1.06 (1.01--1.11)     1.02 (0.97--1.08)   1.02 (1.00--1.05)
   Road dust         1.10 (1.01--1.19)   1.06 (1.01--1.11)   1.12 (1.02--1.22)     1.04 (0.95--1.15)   1.06 (1.02--1.11)
   Sulfur            0.97 (0.94--1.00)   1.00 (0.98--1.01)   0.98 (0.94--1.02)     0.99 (0.94--1.03)   0.98 (0.97--1.00)
   Biomass burning   0.80 (0.66--0.98)   0.97 (0.92--1.03)   1.05 (0.95--1.17)     1.06 (0.95--1.18)   1.00 (0.96--1.03)
   Oil               1.02 (0.86--1.20)   1.02 (0.95--1.10)   1.07 (0.92--1.26)     0.99 (0.82--1.18)   0.98 (0.91--1.05)
   Sea salt          0.96 (0.86--1.07)   0.99 (0.92--1.07)   1.01 (0.92--1.12)     0.95 (0.84--1.08)   0.99 (0.94--1.04)
  L02 model                                                                                            
   Motor vehicles    1.10 (1.01--1.19)   1.03 (0.98--1.09)   1.12 (1.01--1.24)     1.08 (0.98--1.20)   1.03 (0.98--1.08)
   Road dust         1.26 (1.05--1.51)   1.16 (1.02--1.32)   1.28 (1.05--1.55)     1.20 (0.97--1.49)   1.09 (1.00--1.19)
   Sulfur            0.98 (0.92--1.04)   1.01 (0.98--1.05)   0.97 (0.90--1.04)     1.00 (0.92--1.08)   1.00 (0.97--1.03)
   Biomass burning   0.64 (0.46--0.88)   0.93 (0.81--1.06)   0.78 (0.52--1.18)     0.87 (0.62--1.22)   0.95 (0.87--1.04)
   Oil               0.80 (0.56--1.08)   0.84 (0.71--1.00)   0.94 (0.69--1.29)     0.80 (0.58--1.10)   0.92 (0.81--1.05)
   Sea salt          0.91 (0.82--1.16)   0.88 (0.77--1.01)   1.01 (0.79--1.29)     0.95 (0.71--1.27)   0.97 (0.88--1.07)

n = 149 children with asthma, New Haven, Connecticut, August 2000--January 2004. Separate logistic regression analyses were performed for each health outcome. Each model included the six PM~2.5~ sources listed, either as same-day concentrations (L0), or the concentration averaged over the same day and previous 2 days (L02), as well as variables controlling for season, day of week, and date. Logistic regressions were performed using GEE. All ORs are given for a 5-μg/m^3^ increase in source concentration.

###### 

Effect of adding a gaseous co-pollutant to the source exposure model \[OR (95% CI)\].

                                                 Co-pollutants                                               
  -------------------------- ------------------- ------------------- ------------------- ------------------- -------------------
  Wheeze                                                                                                     
   Motor vehicles            1.05 (0.99--1.10)   1.03 (0.98--1.08)   1.05 (0.99--1.11)   1.04 (0.99--1.09)   1.06 (0.97--1.16)
   Road dust                 1.10 (1.01--1.19)   1.11 (1.02--1.20)   1.10 (1.01--1.19)   1.10 (1.01--1.19)   1.11 (1.01--1.23)
   Sulfur                    0.97 (0.94--1.00)   0.96 (0.92--0.99)   0.97 (0.94--1.01)   0.97 (0.93--1.00)   0.95 (0.91--1.00)
   Biomass burning           0.80 (0.66--0.98)   0.79 (0.65--0.98)   0.80 (0.66--0.98)   0.79 (0.64--0.98)   0.74 (0.57--0.97)
   Oil                       1.02 (0.86--1.20)   1.02 (0.87--1.21)   1.02 (0.86--1.20)   1.01 (0.86--1.19)   0.92 (0.62--1.39)
   Sea salt                  0.96 (0.86--1.07)   0.96 (0.85--1.07)   0.96 (0.86--1.08)   0.95 (0.85--1.07)   1.01 (0.72--1.40)
   Co-pollutant                                  1.08 (0.99--1.18)   1.00 (0.94--1.07)   1.02 (0.96--1.09)   1.08 (0.99--1.18)
  Short-acting inhaler use                                                                                   
   Motor vehicles            1.02 (1.00--1.05)   1.02 (0.99--1.04)   1.02 (0.99--1.05)   1.02 (0.99--1.04)   1.02 (0.98--1.07)
   Road dust                 1.06 (1.02--1.11)   1.06 (1.02--1.10)   1.06 (1.02--1.11)   1.06 (1.02--1.11)   1.06 (1.00--1.13)
   Sulfur                    0.98 (0.97--1.00)   0.98 (0.96--1.00)   0.98 (0.96--1.00)   0.98 (0.96--1.00)   0.97 (0.95--1.00)
   Biomass burning           1.00 (0.96--1.03)   1.00 (0.96--1.03)   0.99 (0.96--1.03)   0.99 (0.96--1.03)   0.99 (0.95--1.03)
   Oil                       0.98 (0.91--1.05)   0.98 (0.91--1.05)   0.97 (0.91--1.04)   0.97 (0.91--1.04)   1.03 (0.88--1.22)
   Sea salt                  0.99 (0.94--1.04)   0.99 (0.94--1.04)   0.99 (0.94--1.04)   0.99 (0.94--1.04)   1.01 (0.88--1.15)
   Co-pollutant                                  1.01 (0.97--1.06)   1.02 (0.98--1.05)   1.01 (0.99--1.04)   1.01 (0.97--1.05)

*n* = 149 children with asthma, New Haven, Connecticut, August 2000--January 2004. Separate repeated measures logistic regression analyses using GEE were performed for each health outcome. Each model includes the six particle sources (same-day exposure) as well as season, day of week, and date. Gaseous co-pollutants were added to the source exposure model one at a time. ORs for sources are given for a 5-μg/m^3^ increase in source concentration; ORs for co-pollutants are given for each 20 ppb (NO~2~, ozone), 0.5 ppm (CO), or 5 ppb (SO~2~). Pearson correlations between PM~2.5~ sources and criteria pollutants were \< 0.20 except for motor vehicles with NO~2~ (*r* = 0.49), CO (*r* = 0.59), SO~2~ (*r* = 0.45); road dust with NO~2~ (*r* = 0.37), O~3~ (*r* = 0.58); and oil with CO (*r* = 0.22), SO~2~ (*r* = 0.32).

[^1]: The authors declare they have no competing financial interests.
